Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,197
archived clinical trials in
Atrial Fibrillation

A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
San Diego Managed Care Group
mi
from
Poway, CA
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
San Diego Managed Care Group
mi
from
Poway, CA
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
University of California, San Diego
mi
from
San Diego, CA
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Santa Rosa Cardiology
mi
from
Santa Rosa, CA
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Santa Rosa Cardiology
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
North County Internal Medicine
mi
from
Vista, CA
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
North County Internal Medicine
mi
from
Vista, CA
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Cardiology Associates Of New Haven,Pc
mi
from
Guilford, CT
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Cardiology Associates Of New Haven,Pc
mi
from
Guilford, CT
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Stamford Therapeutics Consortium
mi
from
Stamford, CT
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Stamford Therapeutics Consortium
mi
from
Stamford, CT
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Bay Pines VA Healthcare System
mi
from
Bay Pines, FL
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Bay Pines VA Healthcare System
mi
from
Bay Pines, FL
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Research Alliance, Inc.
mi
from
Clearwater, FL
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Research Alliance, Inc.
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
The Heart & Vascular Institute Of Florida
mi
from
Clearwater, FL
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
The Heart & Vascular Institute Of Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Kim A. Klancke, Md
mi
from
Daytona Beach, FL
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Kim A. Klancke, Md
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
The Heart Group Pl
mi
from
Fort Myers, FL
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
The Heart Group Pl
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Baptist Heart Specialists
mi
from
Jacksonville Beach, FL
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Baptist Heart Specialists
mi
from
Jacksonville Beach, FL
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
St. Vincent's Ambulatory Care
mi
from
Jacksonville, FL
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
St. Vincent's Ambulatory Care
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Michael F. Lesser, Md, Facc Osler Medical Inc.
mi
from
Melbourne, FL
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Michael F. Lesser, Md, Facc Osler Medical Inc.
mi
from
Melbourne, FL
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Center of Sarasota
mi
from
Sarasota, FL
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Center of Sarasota
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
The Broward Heart Group, Pa
mi
from
Tamarac, FL
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
The Broward Heart Group, Pa
mi
from
Tamarac, FL
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Southeast Regional Research Group
mi
from
Columbus, GA
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Southeast Regional Research Group
mi
from
Columbus, GA
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Southeast Regional Research Group
mi
from
Savannah, GA
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Southeast Regional Research Group
mi
from
Savannah, GA
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Fox Valley Clinical Research Center, LLC
mi
from
Aurora, IL
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Fox Valley Clinical Research Center, LLC
mi
from
Aurora, IL
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
North Chicago VA Medical Center
mi
from
North Chicago, IL
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
North Chicago VA Medical Center
mi
from
North Chicago, IL
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Indiana Heart Physicians
mi
from
Indianapolis, IN
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Indiana Heart Physicians
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
The Care Group, LLC
mi
from
Indianapolis, IN
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
The Care Group, LLC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Hutchinson Clinic
mi
from
Hutchinson, KA
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Hutchinson Clinic
mi
from
Hutchinson, KA
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Dr. Jeffrey Chen
mi
from
Lafayette, LA
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Dr. Jeffrey Chen
mi
from
Lafayette, LA
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Peninsula Cardiology Associates
mi
from
Salisbury, MD
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Peninsula Cardiology Associates
mi
from
Salisbury, MD
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Pentucket Medical Associates
mi
from
Haverhill, MA
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Pentucket Medical Associates
mi
from
Haverhill, MA
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Great Lakes Heart Center Of Alpena
mi
from
Alpena, MI
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Great Lakes Heart Center Of Alpena
mi
from
Alpena, MI
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Henry Ford Hospital K-15
mi
from
Detroit, MI
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Henry Ford Hospital K-15
mi
from
Detroit, MI
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Michigan Heart and Vascular Specialists
mi
from
Petoskey, MI
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Michigan Heart and Vascular Specialists
mi
from
Petoskey, MI
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Academic Cardiology Associates PC
mi
from
Rochester Hills, MI
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Academic Cardiology Associates PC
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Tupelo Neurology Clinic, Pa
mi
from
Tupelo, MS
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Tupelo Neurology Clinic, Pa
mi
from
Tupelo, MS
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Missouri Cardiovascular Specialists
mi
from
Columbia, MO
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Missouri Cardiovascular Specialists
mi
from
Columbia, MO
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
University of Missouri
mi
from
Columbia, MO
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Glacier View Cardiology
mi
from
Kalispell, MT
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Glacier View Cardiology
mi
from
Kalispell, MT
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Hunterdon Cardiovascular Associates
mi
from
Flemington, NJ
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Hunterdon Cardiovascular Associates
mi
from
Flemington, NJ
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Capital Cardiology Associates
mi
from
Albany, NY
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Capital Cardiology Associates
mi
from
Albany, NY
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Long Island Heart Associates
mi
from
Mineola, NY
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Long Island Heart Associates
mi
from
Mineola, NY
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Dr William Kufs
mi
from
Saratoga Springs, NY
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Dr William Kufs
mi
from
Saratoga Springs, NY
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Capital Cardiology Associates
mi
from
Troy, NY
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Capital Cardiology Associates
mi
from
Troy, NY
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Terry V. Arnold, Md
mi
from
Lexington, NC
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Terry V. Arnold, Md
mi
from
Lexington, NC
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Pinehurst Medical Clinic
mi
from
Pinehurst, NC
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Pinehurst Medical Clinic
mi
from
Pinehurst, NC
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Sanford Cardiology
mi
from
Sanford, NC
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Sanford Cardiology
mi
from
Sanford, NC
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Ira R. Friedlander, M.D.
mi
from
Canton, OH
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Ira R. Friedlander, M.D.
mi
from
Canton, OH
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Davis Heart and Lung Research Institute
mi
from
Columbus, OH
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Davis Heart and Lung Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Integris Cardiovascular Physicians LLC
mi
from
Oklahoma City, OK
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Integris Cardiovascular Physicians LLC
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
South Oklahoma Heart Research
mi
from
Oklahoma City, OK
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
South Oklahoma Heart Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Oregon Medical Group Clinical Research
mi
from
Eugene, OR
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Oregon Medical Group Clinical Research
mi
from
Eugene, OR
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Hillsboro Cardiology
mi
from
Hillsboro, OR
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Hillsboro Cardiology
mi
from
Hillsboro, OR
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
The Portland Clinic, Llp
mi
from
Portland, OR
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
The Portland Clinic, Llp
mi
from
Portland, OR
Click here to add this to my saved trials
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated:  12/31/1969
Comprehensive Cardiology Consultants
mi
from
Langhorne, PA
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial
Status: Enrolling
Updated: 12/31/1969
Comprehensive Cardiology Consultants
mi
from
Langhorne, PA
Click here to add this to my saved trials